All Stories

  1. Clinical relevance of biological variation of cardiac troponins
  2. Cardiotoxic effects and myocardial injury: the search for a more precise definition of drug cardiotoxicity
  3. High-sensitivity cardiac troponin I and T methods for the early detection of myocardial injury in patients on chemotherapy
  4. Evaluation of reference change values for a hs-cTnI immunoassay using both plasma samples of healthy subjects and patients and quality control samples
  5. Evaluation of analytical performances using standardized analytical protocols and comparison of clinical results of the new ADVIA BNP and NT-proBNP immunoassays for the Centaur XPT platform
  6. A multicenter study for the evaluation of the reference interval for TSH in Italy (ELAS TSH Italian Study)
  7. Obese phenotype and natriuretic peptides in patients with heart failure with preserved ejection fraction
  8. Evaluation of analytical performance of a chemiluminescence enzyme immunoassay (CLEIA) for cTnI using the automated AIA-CL2400 platform
  9. Evaluation of the analytical performance of a new ADVIA immunoassay using the Centaur XPT platform system for the measurement of cardiac troponin I
  10. A Black Swan in clinical laboratory practice: the analytical error due to interferences in immunoassay methods
  11. Evaluation of analytical performance of a new high-sensitivity immunoassay for cardiac troponin I
  12. New issues on measurement of B-type natriuretic peptides
  13. Biotin interference on immunoassay methods: sporadic cases or hidden epidemic?
  14. Predictive Value of NT-proBNP in Patients with Acute Myocardial Infarction
  15. Harmonization protocols for TSH immunoassays: a multicenter study in Italy
  16. Harmonization protocols for thyroid stimulating hormone (TSH) immunoassays: different approaches based on the consensus mean value
  17. Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform
  18. Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance